Evidence map›Paper›PMID 29404229›Full record

ArticleCureus2017

Clinical Implications of a Novel, Iron-containing Fiducial Marker in Radiotherapy for Liver Tumors: An Initial Experience.

Hiroshi Doi, Shogo Harui, Hiroki Nakajima, Akira Ando, Keiji Kamino, Masayuki Fujiwara, Takayoshi Nakajima, Shinichi Ikura, Tsukasa Aihara, Naoki Yamanaka

Open access · diamondAbstract read
In one paragraph

Article in Cureus, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Hiroshi DoiDepartment of Radiology, Hyogo College of Medicine.
Shogo HaruiDepartment of Radiation Oncology, Meiwa Cancer Clinic.
Hiroki NakajimaDepartment of Radiation Oncology, Meiwa Cancer Clinic.
Akira AndoDepartment of Radiation Oncology, Meiwa Cancer Clinic.
Keiji KaminoDepartment of Radiation Oncology, Meiwa Cancer Clinic.
Masayuki FujiwaraDepartment of Radiation Oncology, Meiwa Cancer Clinic.
Takayoshi NakajimaDepartment of Surgery, Meiwa Hospital.
Shinichi IkuraDepartment of Surgery, Meiwa Hospital.
Tsukasa AiharaDepartment of Surgery, Meiwa Hospital.
Naoki YamanakaDepartment of Surgery, Meiwa Hospital.
Cancer Clinic · USMiwa Hospital · JPHyogo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 0.5%-iron-containing fiducial marker, Gold Anchor

Indexed as

fiducial markerhepatocellular carcinomaimage guided radiation therapyintensity modulated radiotherapyliver metastasisstereotactic ablative radiation therapystereotactic body radiation therapy

Identifiers

PMID29404229
PMCPMC5794412
OpenAlexW2773909314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.